New Edge Advisors, LLC Cybin Inc. Transaction History

New Edge Advisors, LLC

  • $15 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$0.38 - $0.65 $1,381 - $2,363
3,636 Added 320.35%
4,771 $1,000
Q1 2023

May 12, 2023
SELL
$0.3 - $0.56 $725 - $1,354
-2,418 Reduced 68.06%
1,135 $0
Q4 2022

Feb 14, 2023
BUY
$0.26 - $0.64 $923 - $2,273
3,553 New
3,553 $1,000

Others Institutions Holding CYBN

# of Institutions
8
Shares Held
66.1K
Call Options Held
0
Put Options Held
0
View Full List

About CYBIN INC.

CYBN Quotes by TradingView
  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $1.65B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email